Skip to main content

Vecuronium Side Effects

Medically reviewed by Last updated on Mar 2, 2022.

Applies to vecuronium: parenteral powder for injection.


Special Alerts:

A standardized concentration for this drug has been established through Standardize 4 Safety (S4S), a national patient safety initiative to reduce medication errors, especially during transitions of care. The drug is included in a standard concentration list which may apply to an IV or oral compounded liquid formulation. For additional information, see the ASHP website [Web].

Side effects include:

Skeletal muscle weakness.

For Healthcare Professionals

Applies to vecuronium: intravenous powder for injection, intravenous solution.


Very rare (less than 0.01%): Hypersensitivity, anaphylactic reaction, anaphylactoid reaction, anaphylactic shock, anaphylactoid shock[Ref]


Rare (0.01% to 0.1%): Prolonged neuromuscular block

Very rare (less than 0.01%): Flaccid paralysis, muscular weakness, steroid myopathy[Ref]


Very rare (less than 0.01%): Bronchospasm, airway complication of anesthesia[Ref]


Very rare (less than 0.01%): Injection site pain, injection site reaction[Ref]


Rare (0.01% to 0.1%): Decreased drug effect/therapeutic response, increased drug effect/therapeutic response

Very rare (less than 0.01%): Face edema[Ref]

Nervous system

Rare (less than 0.1%): Delayed recovery from anesthesia[Ref]


Rare (0.01% to 0.1%): Tachycardia, hypotension

Very rare (less than 0.01%): Circulatory collapse, shock, flushing[Ref]


Very rare (less than 0.01%): Angioneurotic edema, urticaria, rash, erythematous rash[Ref]


1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Cerner Multum, Inc. Australian Product Information.

3. Product Information. Vecuronium Bromide (vecuronium). Hospira Inc. 2019.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.